Paris, May 24th, 2018. Trescal, the international specialist in calibration services, announces the acquisition of RS Calibration, an A2LA accredited calibration, qualification and validation laboratory dedicated to the life science industry.
Founded in 1995 and based in Pleasanton (Northeast of San Francisco), RS Calibration employs 41 people and provides in house or on site calibration and validation services specifically for the Pharmaceutical, Medical Device, and Biotech production environments. The company has high calibration expertise in the FDA and cGMP environments and its sales reached $ 5,5 million in 2017.
The CEO and founder, Ralph Sabiel, will remain in his current position to pursue the development of the company within Trescal Group.
Guillaume Caroit, Trescal Deputy CEO, said: “This acquisition is very important for the development of Trescal in the United States. It will strengthen our coverage in California and reinforces our ability to serve the life science industry. ”
This acquisition is the first to be completed subsequent to OMERS, the defined benefit pension plan for municipal employees in the Province of Ontario, Canada, becoming Trescal’s main shareholder.
****************************
ABOUT TRESCAL
Trescal, international specialist in calibration provides a broad range of services for the test and measuring equipment market. Trescal are represented in 22 countries: Austria, Belgium, Brazil, Canada, Czech Republic, Denmark, France, Germany, Italy, Luxemburg, Malaysia, Mexico, Morocco, Singapore, Spain, Sweden, Switzerland, the Netherlands, United Kingdom, United States, Romania and Tunisia. Supplementing the
standard technical services (verification, calibration and repair of T&M instruments), Trescal offer their expertise for the implementation and acquisition of measurement systems, customized equipment pool management software solutions, metrology and technical support, and training. Trescal operate in +120 owned calibration laboratories and employ over 3250 people across the world. Trescal service 40 000 customers in
various sectors such as Defense, Aerospace, Aeronautics, Automotive, Power Generation & Utilities, Electronics Manufacturing, Communications and Medical & Chemistry. Trescal’s Pro Forma sales reach +300 million Euros.
ABOUT OMERS and OMERS Private Equity
Founded in 1962, OMERS is one of Canada’s largest defined benefit pension plans, with more than $95 billion in net assets, as at December 31, 2017. OMERS invests and administers pensions for more than 482,000 members through originating and managing a diversified portfolio of investments in public markets, private equity, infrastructure and real estate.
OMERS has $10.8 billion of capital invested in private equity assets as at December 31, 2017. OMERS Private Equity, the private equity investment arm of OMERS with a team of investment professionals in London, New York, Singapore and Toronto, seeks to use its significant and differentiated capital base to partner with management teams of industry leading business. For more information, please visit www.omersprivatemarkets.com
